Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy

Por Ning, Jianfang, Wakimoto, Hiroaki
Publicado em 2014

At the Crossroads of Cancer Stem Cells, Radiation Biology and Radiation Oncology

Por Gerweck, Leo E., Wakimoto, Hiroaki
Publicado no Cancer Res (2016)

Immunovirotherapy for glioblastoma

Por Ning, Jianfang, Wakimoto, Hiroaki, Rabkin, Samuel D
Publicado em 2014

Oncolytic herpes simplex virus interactions with the host immune system

Por Saha, Dipongkor, Wakimoto, Hiroaki, Rabkin, Samuel D.
Publicado no Curr Opin Virol (2016)

Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?

Por Kanai, Ryuichi, Wakimoto, Hiroaki, Cheema, Tooba, Rabkin, Samuel D
Publicado em 2010

A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphatidylinositol 3-Kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells

Por Kanai, Ryuichi, Wakimoto, Hiroaki, Martuza, Robert L., Rabkin, Samuel D.
Publicado em 2011

ET-17 TRANSIENT FASTING ENHANCES REPLICATION AND THERAPEUTIC ACTIVITY OF ONCOLYTIC HSV IN GLIOBLASTOMA THERAPY

Por Esaki, Shinichi, Rabkin, Samuel D., Martuza, Robert L., Wakimoto, Hiroaki
Publicado em 2014

Transient fasting enhances replication of oncolytic herpes simplex virus in glioblastoma

Por Esaki, Shinichi, Rabkin, Samuel D, Martuza, Robert L, Wakimoto, Hiroaki
Publicado no Am J Cancer Res (2016)

Encapsulated Stem Cells Loaded With Hyaluronidase-expressing Oncolytic Virus for Brain Tumor Therapy

Por Martinez-Quintanilla, Jordi, He, Derek, Wakimoto, Hiroaki, Alemany, Ramon, Shah, Khalid
Publicado no Mol Ther (2015)

Oncolytic Herpes Simplex Virus Counteracts the Hypoxia-Induced Modulation of Glioblastoma Stem-Like Cells

Por Sgubin, Donatella, Wakimoto, Hiroaki, Kanai, Ryuichi, Rabkin, Samuel D., Martuza, Robert L.
Publicado em 2012

Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastoma

Por Lu, Lei, Saha, Dipongkor, Martuza, Robert L., Rabkin, Samuel D., Wakimoto, Hiroaki
Publicado no J Neurooncol (2014)

STEM-18 CULTURE CONDITION-INDUCED MESENCHYMAL TRANSITION IN PATIENT-DERIVED GLIOBLASTOMA STEM CELLS

Por Teng, Jian, da Hora, Cintia Carla, Kantar, Rami, Wakimoto, Hiroaki, Batchelor, Tracy, Badr, Christian, Tannous, Bakhos
Publicado no Neuro Oncol (2015)

Complement Depletion Facilitates the Infection of Multiple Brain Tumors by an Intravascular, Replication-Conditional Herpes Simplex Virus Mutant

Por Ikeda, Keiro, Wakimoto, Hiroaki, Ichikawa, Tomotsugu, Jhung, Sarah, Hochberg, Fred H., Louis, David N., Chiocca, E. Antonio
Publicado em 2000

Effect of γ34.5 Deletions on Oncolytic Herpes Simplex Virus Activity in Brain Tumors

Por Kanai, Ryuichi, Zaupa, Cecile, Sgubin, Donatella, Antoszczyk, Slawomir J., Martuza, Robert L., Wakimoto, Hiroaki, Rabkin, Samuel D.
Publicado em 2012

Enhanced anti-tumor efficacy of low dose etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts

Por Cheema, Tooba A., Kanai, Ryuichi, Kim, Geon Woo, Wakimoto, Hiroaki, Passer, Brent, Rabkin, Samuel D., Martuza, Robert L.
Publicado em 2011

MNGO-16 ESTABLISHMENT OF A PATIENT - DERIVED ORTHOTOPIC MALIGNANT MENINGIOMA MODEL FOR THE DEVELOPMENT OF TARGETED THERAPY

Por Nigim, Fares, Rabkin, Samuel D., Brastianos, Priscilla, Ramesh, Vijaya, Cahill, Daniel, Santagata, Sandro, Martuza, Robert L., Wakimoto, Hiroaki
Publicado no Neuro Oncol (2015)

ATPS-85 2-HYDROXYGLUTARATE DEPLETION IS NOT SUFFICIENT TO INHIBIT GROWTH OF SEVERAL PROGRESSIVE IDH1 MUTANT SOLID CANCER TYPES

Por Tateishi, Kensuke, Wakimoto, Hiroaki, Loebel, Franziska, Lelic, Nina, Zhao, Dan, Batchelor, Tracy, Iafrate, John, Chi, Andrew, Cahill, Daniel
Publicado no Neuro Oncol (2015)

NT-33 NAD+ SYNTHESIS INHIBITION AS A THERAPEUTIC STRATEGY FOR GLIOBLASTOMA WITH MYC AMPLIFICATION

Por Tateishi, Kensuke, Lelic, Nina, Ho, Quan H., Esakl, Shinichi, Iafrate, John A., Cahill, Daniel P., Chi, Andrew S., Wakimoto, Hiroaki
Publicado em 2014

Multimechanistic Tumor Targeted Oncolytic Virus Overcomes Resistance in Brain Tumors

Por Tamura, Kaoru, Wakimoto, Hiroaki, Agarwal, Aayush S, Rabkin, Samuel D, Bhere, Deepak, Martuza, Robert L, Kuroda, Toshihiko, Kasmieh, Randa, Shah, Khalid
Publicado em 2013

Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model

Por Cheema, Tooba A., Wakimoto, Hiroaki, Fecci, Peter E., Ning, Jianfang, Kuroda, Toshihiko, Jeyaretna, Deva S., Martuza, Robert L., Rabkin, Samuel D.
Publicado em 2013